Your own stem cells could rebuild a dying hip bone
NCT ID NCT07101562
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new way to treat early-stage avascular necrosis (bone death) of the hip. Doctors take a patient's own bone marrow stem cells, grow them on a special bone scaffold in the lab, and then implant this 'tissue-engineered bone' into the damaged area. The goal is to see if this can regrow healthy bone, relieve pain, and improve hip function, potentially avoiding the need for a hip replacement. The trial will enroll 30 adults aged 20 to 65 with non-traumatic early-stage femoral head necrosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tissue-engineered bone made from the patient's own bone marrow stem cells
- What this could lead to
- If it works, this could offer a way to repair damaged bone in the hip and delay or avoid the need for a total hip replacement.
- What could go wrong
- This is a small early study with only 30 people, so results may not apply to everyone. There is also a risk the treatment may not prevent further collapse of the hip joint.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS OF FEMUR HEAD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Xinxiang Medical College
RECRUITINGXinxiang, Henan, 453000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.